MNKD MannKind Corp

$3.75

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/1/2025

About MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.

Website: https://www.mannkindcorp.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
899460
Address
30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE, CA, US
Valuation
Market Cap
$1.38B
P/E Ratio
45.40
PEG Ratio
-0.23
Price to Book
0.00
Performance
EPS
$0.10
Dividend Yield
—
Profit Margin
9.66%
ROE
0.00%
Technicals
50D MA
$5.16
200D MA
$5.95
52W High
$7.63
52W Low
$4.06
Fundamentals
Shares Outstanding
304M
Target Price
$10.29
Beta
1.21

MNKD EPS Estimates vs Actual

● Estimated
● Actual

MNKD News & Sentiment

Jul 31, 2025 • Zacks Commentary NEUTRAL
AbCellera Biologics Inc. ( ABCL ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ABCELLERA BIOLG (ABCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jul 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Analysts Estimate MannKind ( MNKD ) to Report a Decline in Earnings: What to Look Out for
MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jun 25, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Amarin ( AMRN ) Soars 27.3%: Is Further Upside Left in the Stock?
Amarin (AMRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Jun 11, 2025 • Benzinga SOMEWHAT-BULLISH
Top 3 Health Care Stocks That May Rocket Higher This Quarter - INVO Fertility ( NASDAQ:IVF ) , MannKind ( NASDAQ:MNKD )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Jun 09, 2025 • Benzinga SOMEWHAT-BULLISH
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin ( Afrezza® ) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23 - MannKind ( NASDAQ:MNKD )
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 ( GLOBE NEWSWIRE ) -- MannKind Corporation MNKD, a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will showcase inhaled ...
Jun 09, 2025 • GlobeNewswire NEUTRAL
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin ( Afrezza® ) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Session ...
Sentiment Snapshot

Average Sentiment Score:

0.187
50 articles with scored sentiment

Overall Sentiment:

Bullish

MNKD Reported Earnings

Feb 25, 2025
Dec 31, 2024 (Pre market)
-0.0 Surprise
  • Reported EPS: $0.03
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: -15.0%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.05
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 66.7%
Aug 07, 2024
Jun 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.01
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: -200.0%
May 08, 2024
Mar 31, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 33.3%
Feb 27, 2024
Dec 31, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: -57.0%
Nov 07, 2023
Sep 30, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: 150.0%
Aug 07, 2023
Jun 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.04
  • Whisper: —
  • Surprise %: 50.0%
May 09, 2023
Mar 31, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $-0.04
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 20.0%
Feb 22, 2023
Dec 31, 2022 (Pre market)
-0.01 Surprise
  • Reported EPS: $-0.07
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: -16.7%

Financials